Abstract
Traumatic brain injury affects over a million Americans annually, but pharmacological therapy remains limited. Current standards of care in acute, subacute and chronic phases of injury are primarily supportive. This review discusses pharmacological strategies and future directions in patient treatment emphasizing pleiotropic agents targeting inflammation, oxidative damage, and glutamate excitotoxicity.
Mini-Reviews in Medicinal Chemistry
Title: Pharmacological Strategies for Neuroprotection in Traumatic Brain Injury
Volume: 8 Issue: 7
Author(s): J. S. Jennings, A. M. Gerber and M. L. Vallano
Affiliation:
Abstract: Traumatic brain injury affects over a million Americans annually, but pharmacological therapy remains limited. Current standards of care in acute, subacute and chronic phases of injury are primarily supportive. This review discusses pharmacological strategies and future directions in patient treatment emphasizing pleiotropic agents targeting inflammation, oxidative damage, and glutamate excitotoxicity.
Export Options
About this article
Cite this article as:
Jennings S. J., Gerber M. A. and Vallano L. M., Pharmacological Strategies for Neuroprotection in Traumatic Brain Injury, Mini-Reviews in Medicinal Chemistry 2008; 8 (7) . https://dx.doi.org/10.2174/138955708784567377
DOI https://dx.doi.org/10.2174/138955708784567377 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
CNS & Neurological Disorders - Drug Targets Progress in COX-2 Inhibitors: A Journey So Far
Current Medicinal Chemistry Thrombolytic Treatment of Cardiac Myxoma-Induced Ischemic Stroke: A Review
Current Drug Safety Treatment for Radiation-Induced Pulmonary Late Effects: Spoiled for Choice or Looking in the Wrong Direction?
Current Drug Targets Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
CNS & Neurological Disorders - Drug Targets Systems Biology: A Powerful Tool for Drug Development
Current Topics in Medicinal Chemistry Halving Your Cake and Eating it, Too: A Case-based Discussion and Review of Metabolic Rehabilitation for Obese Adults with Diabetes
Current Diabetes Reviews The Development of Stem Cell-Based Treatment for Acute Ischemic Cerebral Injury
Current Stem Cell Research & Therapy The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress
Current Neuropharmacology Magnetoencephalography in Fetuses and Neonates: A Review
Current Pediatric Reviews Immunology and Epilepsy: Clinical and Experimental Evidence
Current Immunology Reviews (Discontinued) Potential Therapeutics for Vascular Cognitive Impairment and Dementia
Current Neuropharmacology Clinical Considerations of Focal Drug Delivery in Cancer Treatment
Current Drug Delivery Estrogen Receptor Signaling: Impact on Cell Functions
Current Signal Transduction Therapy Brain Drug Delivery System: An Overview
Current Drug Therapy Propitious Profile of Peppery Piperine
Current Molecular Pharmacology Key Role of Mitochondria in Alzheimer’s Disease Synaptic Dysfunction
Current Pharmaceutical Design Non-Respiratory Manifestations of COVID-19 and Pathophysiological Evidences
New Emirates Medical Journal Mn (III) Tetrakis (4-Benzoic Acid) Porphyrin Protects Against Neuronal and Glial Oxidative Stress and Death After Spinal Cord Injury
CNS & Neurological Disorders - Drug Targets The Effect of SEX/Gender on Cardiovascular Pharmacology
Current Pharmaceutical Design